Coronary Artery Disease Test | GeneType | Genetic Technologies

Coronary artery disease is the number one killer in the US1

Know your risk. To reduce your risk.

Colorectal Cancer

Do you know which factors influence your risk of coronary artery disease?

Multi Test risk reduction plan with Doctor

Coronary artery disease is largely preventable2

It is with a comprehensive risk assessment that you and your health provider may be able to enable effective management of modifiable risk factors.1

Is geneType for Coronary Artery Disease right for you?

GeneType for Coronary Artery Disease is appropriate for:

  • Adults 40-70 years old
  • Non-Hispanic Whites

 

Multi Test risk reduction plan with Doctor

Simple, Actionable Results

GeneType reports help you and your health provider translate your personal clinical, family and genetic data into an actionable preventable health plan.

Unlike other tests, your test results are provided in simple language that you can understand.

Key features of the report:

  • 10-year risk score your health provider may use to tailor risk-reducing recommendations for you
  • Recommendations based on the latest AAC/AHA guidelines

 

Sample patient report

Personalized risk score. Personalized health plan. 

Risk reducing options exist for adults at borderline, intermediate and high risk of coronary artery disease. 

 

Have questions? We have answers.

If your question is not shown here, please contact us directly.

Is this test reimbursed by insurance?

No. At this time geneType is a self-pay test. However, you may use FSA/HSA to pay for the test.

Does this test cover all the coronary artery disease risk factors?

Coronary artery disease is a multifactorial disease and it is not possible to incorporate all potential risk factors into a risk prediction model. Test results should be interpreted by a health provider in the context of your clinical and family history.

I bought a different test online and it is showing I had a high polygenic risk of coronary artery disease, should I retest with geneType?

Yes.

While there are other companies out there that provide random lists of genetic markers that are associated with coronary artery disease, there are no checks and balances associated with the results they provide. Most of the markers they pull from peer-reviewed publications without cross validating the markers. And more importantly, geneType goes through rigorous statistical validation of the genetic component prior to integrating it into the full model. The fully integrated geneType model is then validated separately.

Know your risk of coronary artery disease so you can take action

Interested in ordering more than one disease? Order geneType Multi-Test.

See individual disease pages for more information about each test.

The Multi-Risk suite of tests is for adults 40-69 years of age. At maximum, a woman would be eligible for 5 diseases in the panel; a man would be eligible for 4. If patient is younger than 40, they may qualify for geneType's breast or colorectal risk assessments only.

Coming soon: melanoma, pancreatic cancer and atrial fibrillation geneType tests. Patient eligibility dependent on personal medical history, age, sex and self-identified race/ethnicity

What’s happening?

References

 

1. John Hopkins Medicine. Coronary Artery Disease: Prevention, Treatment and Research. Accessed June 2022.
2. Fryar CD et al. NCHS Data Brief 2012(103):1-8.

Accredited For Compliance With NPAAC Standards And ISO 15189

CLIA Number 99D2023356